InvestorsObserver
×
News Home

Is Sonnet BioTherapeutics Holdings, Inc. (SONN) Stock at the Top of the Biotechnology Industry?

Tuesday, October 24, 2023 10:27 AM | InvestorsObserver Analysts

Mentioned in this article

Is Sonnet BioTherapeutics Holdings, Inc. (SONN) Stock at the Top of the Biotechnology Industry?

A rating of 79 puts Sonnet BioTherapeutics Holdings, Inc. (SONN) near the top of the Biotechnology industry according to InvestorsObserver. Sonnet BioTherapeutics Holdings, Inc.'s score of 79 means it scores higher than 79% of stocks in the industry. Sonnet BioTherapeutics Holdings, Inc. also received an overall rating of 58, putting it above 58% of all stocks. Biotechnology is ranked 74 out of the 148 industries.

Overall Score - 58
SONN has an Overall Score of 58. Find out what this means to you and get the rest of the rankings on SONN!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 58 means the stock is more attractive than 58 percent of stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Sonnet BioTherapeutics Holdings, Inc. Stock Today?

Sonnet BioTherapeutics Holdings, Inc. (SONN) stock is trading at $2.05 as of 10:19 AM on Tuesday, Oct 24, a rise of $0.03, or 1.74% from the previous closing price of $2.02. The stock has traded between $2.03 and $2.11 so far today. Volume today is low. So far 4,563 shares have traded compared to average volume of 36,726 shares. Click Here to get the full Stock Report for Sonnet BioTherapeutics Holdings, Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App